BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 2433953)

  • 1. Carcinoembryonic antigen and nonspecific cross-reacting antigen in thyroid cancer. An immunocytochemical study using polyclonal and monoclonal antibodies.
    Schröder S; Klöppel G
    Am J Surg Pathol; 1987 Feb; 11(2):100-8. PubMed ID: 2433953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinoembryonic antigen and nonspecific cross-reacting antigen in medullary carcinoma of the thyroid.
    Kakudo K; Takami H; Katayama S; Matsuura N; Kamoshida S; Miyauchi A; Watanabe K
    Acta Pathol Jpn; 1990 Apr; 40(4):261-6. PubMed ID: 2371832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical demonstration of nonspecific cross-reacting antigen in normal and neoplastic human tissues using a monoclonal antibody. Comparison with carcinoembryonic antigen localization.
    Tsutsumi Y; Onoda N; Misawa M; Kuroki M; Matsuoka Y
    Acta Pathol Jpn; 1990 Feb; 40(2):85-97. PubMed ID: 2187320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential reactivities of carcinoembryonic antigen (CEA) and CEA-related monoclonal and polyclonal antibodies in common epithelial malignancies.
    Sheahan K; O'Brien MJ; Burke B; Dervan PA; O'Keane JC; Gottlieb LS; Zamcheck N
    Am J Clin Pathol; 1990 Aug; 94(2):157-64. PubMed ID: 1695478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibody recognizing a carcinoembryonic antigen epitope differentially expressed in human colonic carcinoma versus normal adult colon tissues.
    Zhang HZ; Ordonez NG; Batsakis JG; Chan JC
    Cancer Res; 1989 Oct; 49(20):5766-73. PubMed ID: 2477148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies to carcinoembryonic antigen: a systematic analysis of antibody specificities by using related normal antigens and evidence for allotypic determinants on carcinoembryonic antigen.
    Kuroki M; Kuroki M; Koga Y; Matsuoka Y
    J Immunol; 1984 Oct; 133(4):2090-7. PubMed ID: 6206151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial markers in thyroid carcinoma: an immunoperoxidase study.
    Wilson NW; Pambakian H; Richardson TC; Stokoe MR; Makin CA; Heyderman E
    Histopathology; 1986 Aug; 10(8):815-29. PubMed ID: 2428725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinoembryonic antigen in medullary thyroid carcinoma: an immunohistochemical study applying six novel monoclonal antibodies.
    Dasović-Knezević M; Børmer O; Holm R; Høie J; Sobrinho-Simões M; Nesland JM
    Mod Pathol; 1989 Nov; 2(6):610-7. PubMed ID: 2587568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of five monoclonal anti-CEA antibodies with different epitope specificities to various carcinoma tissues.
    Wagener C; Petzold P; Köhler W; Totović V
    Int J Cancer; 1984 Apr; 33(4):469-75. PubMed ID: 6200447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunophenotypic analysis of colorectal carcinomas with monoclonal antibodies 47D10 and anti-carcinoembryonic antigen.
    Keep JC; Benson AB; Sullivan MD; Carney WP; Rosen ST; Radosevich JA
    Tumour Biol; 1989; 10(3):153-63. PubMed ID: 2762739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical analysis of pulmonary and pleural neoplasms using a monoclonal antibody (47D10) which reacts with nonspecific cross-reacting antigen.
    Radosevich JA; Robinson PG; Carney WP; Warren W; Rosen ST; Gould VE
    Tumour Biol; 1989; 10(6):281-8. PubMed ID: 2480629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies against CEA-related components discriminate between pancreatic duct type carcinomas and nonneoplastic duct lesions as well as nonduct type neoplasias.
    Bätge B; Bosslet K; Sedlacek HH; Kern HF; Klöppel G
    Virchows Arch A Pathol Anat Histopathol; 1986; 408(4):361-74. PubMed ID: 3004013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological heterogeneity of carcinoembryonic antigen: immunohistochemical detection of carcinoembryonic antigen determinants in colonic tumors with monoclonal antibodies.
    Primus FJ; Kuhns WJ; Goldenberg DM
    Cancer Res; 1983 Feb; 43(2):693-701. PubMed ID: 6184153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of carcinoembryonic or related cross-reacting antigens in primary pediatric neuroectodermal brain tumors.
    Bodey B; Siegel SE; Peacock JS
    Mod Pathol; 1992 Jul; 5(4):432-8. PubMed ID: 1323111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic heterogeneity of carcinoembryonic antigen in the circulation defined by monoclonal antibodies against the carbohydrate moiety of carcinoembryonic antigen and closely related antigens.
    Matsunaga A; Kuroki M; Higuchi H; Arakawa F; Takakura K; Okamoto N; Matsuoka Y
    Cancer Res; 1987 Jan; 47(1):56-61. PubMed ID: 2431767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human alveolar macrophage-56 and carcinoembryonic antigen monoclonal antibodies in the differential diagnosis between primary ovarian and metastatic gastrointestinal carcinomas.
    Fowler LJ; Maygarden SJ; Novotny DB
    Hum Pathol; 1994 Jul; 25(7):666-70. PubMed ID: 8026826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological heterogeneity of carcinoembryonic antigen: antigenic determinants on carcinoembryonic antigen distinguished by monoclonal antibodies.
    Primus FJ; Newell KD; Blue A; Goldenberg DM
    Cancer Res; 1983 Feb; 43(2):686-92. PubMed ID: 6184152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunocytochemical evaluation of human esophageal neoplasms and preneoplastic lesions for beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen.
    Burg-Kurland CL; Purnell DM; Combs JW; Hillman EA; Harris CC; Trump BF
    Cancer Res; 1986 Jun; 46(6):2936-43. PubMed ID: 2421889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen.
    Purnell DM; Heatfield BM; Trump BF
    Cancer Res; 1984 Jan; 44(1):285-92. PubMed ID: 6197163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CEA and non-specific cross-reacting antigen (NCA) in medullary carcinomas of the thyroid.
    Burtin P; Calmettes C; Fondaneche MC
    Int J Cancer; 1979 Jun; 23(6):741-5. PubMed ID: 89098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.